Brooklyn Investment Group’s Pulmonx LUNG Stock Holding History

Brooklyn Investment Group’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,198	Closed	-$3.1K	–	1836
2025 Q2	$3.1K	Buy	+1,198	New	+$4.73K	﹤0.01%	2640

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KLP

Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Brooklyn Investment Group's LUNG Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Pulmonx (LUNG) in Q3 2025, closing a stake of 1,198 shares — an estimated $3.1K sold.

Brooklyn Investment Group first reported a position in LUNG in Q2 2025 and held it in 1 quarter. The position peaked at $3.1K in Q2 2025. 107 funds tracked by Wall St. Rank hold LUNG as of Q3 2025.

Brooklyn Investment Group reported no remaining Pulmonx position as of Q3 2025 after selling out during the quarter.
Brooklyn Investment Group sold 1,198 Pulmonx shares in Q3 2025, an estimated $3.1K.
Brooklyn Investment Group first reported a position in Pulmonx in Q2 2025 and held it in 1 quarter.
Brooklyn Investment Group's Pulmonx position peaked at $3.1K in Q2 2025.
107 funds tracked by Wall St. Rank held Pulmonx as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.